Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 311, Issue 1, 2016, Pages H54-H63

  Emelyanova, Larisa ^a   Ashary, Zain ^a   Cosic, Milanka ^a   Negmadjanov, Ulugbek ^a   Ross, Gracious ^a   Rizvi, Farhan ^a   Olet, Susan ^b   Kress, David ^a   Sra, Jasbir ^a   Jamil Tajik, A ^a   Holmuhamedov, Ekhson L ^a   Shi, Yang ^a   Jahangir, Arshad ^a,b  

^a AURORA SINAI MEDICAL CENTER   (United States)

^b Aurora Health Care   (United States)

Author keywords

4 hydroxynonenal protein adducts; Atrial fibrillation; Electron transport chain complexes; Humans; Mitochondria; Oxidative phosphorylation; Oxidative stress; Superoxide

Indexed keywords

4 HYDROXYNONENAL; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; 4-HYDROXY-2-NONENAL; ALDEHYDE; MULTIENZYME COMPLEX; SUPEROXIDE;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; COMORBIDITY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM APPENDAGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; OPEN HEART SURGERY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SUBUNIT; CARDIAC MUSCLE CELL; CASE CONTROL STUDY; DISEASE COURSE; DOWN REGULATION; ENZYMOLOGY; HEART ATRIUM; HEART MITOCHONDRION; METABOLISM; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALDEHYDES; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DOWN-REGULATION; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; SUPEROXIDES;

EID: 84983770722     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00699.2015     Document Type: Article

References (62)

1. Akar FG, Aon MA, Tomaselli GF, O’Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115: 3527–3535, 2005.
2. Alasady M, Shipp NJ, Brooks AG, Lim HS, Lau DH, Barlow D, Kuklik P, Worthley MI, Roberts-Thomson KC, Saint DA, Abhayaratna W, Sanders P. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circ Arrhythm Electrophysiol 6: 738–745, 2013.
3. Anderson EJ, Efird JT, Davies SW, O’Neal WT, Darden TM, Thayne KA, Katunga LA, Kindell LC, Ferguson B, Anderson CA, Chitwood WR, Koutlas TC, Williams JM, Rodriguez E, Kypson AP. Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc 3: e000713, 2014.
4. Anonymous. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854: 1–452, 1995.
5. Aon MA, Cortassa S, Akar FG, Brown DA, Zhou L, O’Rourke B. From mitochondrial dynamics to arrhythmias. Int J Biochem Cell Biol 41: 1940–1948, 2009.
6. Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 47: 788–796, 2000.
7. Bacsi A, Woodberry M, Widger W, Papaconstantinou J, Mitra S, Peterson JW, Boldogh I. Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells. Mitochondrion 6: 235–244, 2006.
8. Barbey O, Pierre S, Duran MJ, Sennoune S, Levy S, Maixent JM. Specific up-regulation of mitochondrial F0F1-ATPase activity after short episode of atrial fibrillation in sheep. J Cardiovasc Electrophysiol 11: 432–438, 2000.
9. Becker L, Kling E, Schiller E, Zeh R, Schrewe A, Hölter SM, Mossbrugger I, Calzada-Wack J, Strecker V, Wittig I, Dumitru I, Wenz T, Bender A, Aichler M, Janik D, Neff F, Walch A, Quintanilla-Fend L, Floss T, Bekeredjian R, Gailus-Durner V, Fuchs H, Wurst W, Meitinger T, Prokisch H, de Angelis MH, Klopstock T. MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy. PLoS One 9: e114918, 2014.
10. Bergmeyer HU (Editor). Methods of Enzymatic Analysis (2nd ed.). New York: Verlag Chemie Weinheim Academic, 1974, vol. 1.
11. Brown DA, Aon MA, Frasier CR, Sloan RC, Maloney AH, Anderson EJ, O’Rourke B. Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization. J Mol Cell Cardiol 48: 673–679, 2010.
12. Brown DA, O’Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res 88: 241–249, 2010.
13. Bukowska A, Schild L, Keilhoff G, Hirte D, Neumann M, Gardemann A, Neumann KH, Röhl FW, Huth C, Goette A, Lendeckel U. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med (Maywood) 233: 558–574, 2008.
14. Carroll J, Fearnley IM, Skehel JM, Shannon RJ, Hirst J, Walker JE. Bovine complex I is a complex of 45 different subunits. J Biol Chem 281: 32724–32727, 2006.
15. Cecchini G. Function and structure of complex II of the respiratory chain. Annu Rev Biochem 72: 77–109, 2003.
16. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, Redfield MM. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 284: H1313–H1320, 2003.
17. Chaudhary KR, El-Sikhry H, Seubert JM. Mitochondria and the aging heart. J Geriatr Cardiol 8: 159–167, 2011.
18. Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res 114: 524–537, 2014.
19. Chouchani ET, Methner C, Buonincontri G, Hu CH, Logan A, Sawiak SJ, Murphy MP, Krieg T. Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy. PLoS One 9: e94157, 2014.
20. Cordero-Reyes AM, Gupte AA, Youker KA, Loebe M, Hsueh WA, Torre-Amione G, Taegtmeyer H, Hamilton DJ. Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function. J Mol Cell Cardiol 68: 98–105, 2014.
21. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112: 1266–1273, 2005.
22. Friedman JR, Nunnari J. Mitochondrial form and function. Nature 505: 335–343, 2014.
23. Griffiths ER, Friehs I, Scherr E, Poutias D, McGowan FX, Del Nido PJ. Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress. J Thorac Cardiovasc Surg 139: 1609–17, 2010.
24. Griffiths EJ. Mitochondria and heart disease. Adv Exp Med Biol 942: 249–267, 2012.
25. Holmuhamedov EL, Oberlin A, Short K, Terzic A, Jahangir A. Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide. PLoS One 7: e44667, 2012.
26. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64: e1–e76, 2014. [Erratum. J Am Coll Cardiol 64: December 2, 2014, p. 2305–2307.]
27. Kadenbach B. Introduction to mitochondrial oxidative phosphorylation. Adv Exp Med Biol 748: 1–11, 2012.
28. Kalifa J, Maixent JM, Chalvidan T, Dalmasso C, Colin D, Cozma D, Laurent P, Deharo JC, Djiane P, Cozzone P, Bernard M. Energetic metabolism during acute stretch-related atrial fibrillation. Mol Cell Biochem 317: 69–75, 2008.
29. Karamanlidis G, Lee CF, Garcia-Menendez L, Kolwicz SC Jr, Suthammarak W, Gong G, Sedensky MM, Morgan PG, Wang W, Tian R. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab 18: 239–250, 2013.
30. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 51: 68–74, 2008.
31. Lashin OM, Szweda PA, Szweda LI, Romani AM. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic Biol Med 40: 886–896, 2006.
32. Lin PH, Lee SH, Su CP, Wei YH. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 35: 1310–1318, 2003.
33. Marín-García J, Goldenthal MJ, Moe GW. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res 52: 103–110, 2001.
34. Mathew ST, Patel J, Joseph S. Atrial fibrillation: mechanistic insights and treatment options. Eur J Intern Med 20: 672–681, 2009.
35. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104: 174–180, 2001.
36. Mirza M, Shen WK, Sofi A, Tran C, Jahangir A, Sultan S, Khan U, Viqar M, Cho C, Jahangir A. Frequent periodic leg movement during sleep is an unrecognized risk factor for progression of atrial fibrillation. PLoS One 8: e78359, 2013.
37. Mirza M, Strunets A, Shen WK, Jahangir A. Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med 28: 555–573, 2012.
38. Montaigne D, Marechal X, Lefebvre P, Modine T, Fayad G, Dehondt H, Hurt C, Coisne A, Koussa M, Remy-Jouet I, Zerimech F, Boulanger E, Lacroix D, Staels B, Neviere R. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops. J Am Coll Cardiol 62: 1466–1473, 2013.
39. Moreno-Lastres D, Fontanesi F, García-Consuegra I, Martín MA, Arenas J, Barrientos A, Ugalde C. Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab 15: 324–325, 2012.
40. Moslehi J, DePinho RA, Sahin E. Telomeres and mitochondria in the aging heart. Circ Res 110: 1226–1237, 2012.
41. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131: 434–441, 2015.
42. Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC Jr. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53: 1652–1657, 2007.
43. Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 57: 577–585, 2011.
44. Okada A, Kashima Y, Tomita T, Takeuchi T, Aizawa K, Takahashi M, Ikeda U. Characterization of cardiac oxidative stress levels in patients with atrial fibrillation. Heart Vessels 31: 80–87, 2016.
45. Pathak RK, Mahajan R, Lau DH, Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol 31: 203–210, 2015.
46. Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, Siddiqui SA, Raghavakaimal S, Terzic A, Jahangir A. Aginginduced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev 129: 304–312, 2008.
47. Reilly SN, Jayaram R, Nahar K, Antoniades C, Verheule S, Channon KM, Alp NJ, Schotten U, Casadei B. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124: 1107–1117, 2011.
48. Rutledge C, Dudley S. Mitochondria and arrhythmias. Expert Rev Cardiovasc Ther 11: 799–801, 2013.
49. Schwarz K, Siddiqi N, Singh S, Neil CJ, Dawson DK, Frenneaux MP. The breathing heart—mitochondrial respiratory chain dysfunction in cardiac disease. Int J Cardiol 171: 134–143, 2014.
50. Seppet E, Eimre M, Peet N, Paju K, Orlova E, Ress M, Kõvask S, Piirsoo A, Saks VA, Gellerich FN, Zierz S, Seppet EK. Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery. Mol Cell Biochem 270: 49–61, 2005.
51. Shimano M, Shibata R, Inden Y, Yoshida N, Uchikawa T, Tsuji Y, Murohara T. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 6: 935–940, 2009.
52. Strunets A, Mirza M, Sra J, Jahangir A. Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. Expert Rev Clin Pharmacol 6: 677–689, 2013.
53. Takigawa M, Takahashi A, Kuwahara T, Okubo K, Takahashi Y, Watari Y, Takagi K, Fujino T, Kimura S, Hikita H, Tomita M, Hirao K, Isobe M. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation. Circ Arrhythm Electrophysiol 7: 267–273, 2014.
54. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484–509, 1996.
55. Trumbeckaite S, Opalka JR, Neuhof C, Zierz S, Gellerich FN. Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur J Biochem 268: 1422–1429, 2001.
56. Tsuboi M, Hisatome I, Morisaki T, Tanaka M, Tomikura Y, Takeda S, Shimoyama M, Ohtahara A, Ogino K, Igawa O, Shigemasa C, Ohgi S, Nanba E. Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation. Eur J Clin Invest 31: 489–496, 2001.
57. Turagam MK, Downey FX, Kress DC, Sra J, Tajik AJ, Jahangir A. Pharmacological strategies for prevention of postoperative atrial fibrillation. Expert Rev Clin Pharmacol 8: 233–250, 2015.
58. Turagam MK, Mirza M, Werner PH, Sra J, Kress DC, Tajik AJ, Jahangir A. Circulating biomarkers predictive of postoperative atrial fibrillation. Cardiol Rev 24: 76–87, 2016.
59. van Bragt KA, Nasrallah HM, Kuiper M, Luiken JJ, Schotten U, Verheule S. Atrial supply-demand balance in healthy adult pigs: coronary blood flow, oxygen extraction, and lactate production during acute atrial fibrillation. Cardiovasc Res 101: 9–19, 2014.
60. Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens XH, Nattel S, Dobrev D. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129: 145–156, 2014.
61. Yang KC, Bonini MG, Dudley SC Jr. Mitochondria and arrhythmias. Free Radic Biol Med 71: 351–361, 2014.
62. Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P, Weiss JN, Cai H. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol 62: 72–79, 2013.